Scotté, F., Schwartzberg, L., Iihara, H., Aapro, M., Gralla, R. J., Hesketh, P. J., . . . Herrstedt, J. (2024). 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Supportive care in cancer, 32(1), . https://doi.org/10.1007/s00520-023-08222-3
Chicago-Zitierstil (17. Ausg.)Scotté, Florian, Lee Schwartzberg, Hirotoshi Iihara, Matti Aapro, Richard J. Gralla, Paul J. Hesketh, Karin Jordan, Ronald Chow, und Jørn Herrstedt. "2023 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following Moderately Emetic Risk Antineoplastic Agents." Supportive Care in Cancer 32, no. 1 (2024). https://doi.org/10.1007/s00520-023-08222-3.
MLA-Zitierstil (9. Ausg.)Scotté, Florian, et al. "2023 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following Moderately Emetic Risk Antineoplastic Agents." Supportive Care in Cancer, vol. 32, no. 1, 2024, https://doi.org/10.1007/s00520-023-08222-3.